Price Transparency Slowdown May Aid Strategic Response

Delays are hitting some aspects of the federal price transparency agenda — the complex web of laws, rules and regulations targeting insurers, providers and pharmacy stakeholders, among others. But policy experts say it’s not time to sit back and wait.

That’s what a panel of payer- and provider-focused insiders from the Advisory Board recommended during a Dec. 1 webinar covering federal transparency requirements for the health care sector.

0 Comments
© 2022 MMIT

Freelance Reporter Freelance Reporter

Related Posts

https://www.mmitnetwork.com/wp-content/uploads/2022/01/WordPress-Featured_AdobeStock_273651434.jpg
January 21

Biden Admin Aims to Stymie MLR Inflation Among ACA Plans

READ MORE
https://www.mmitnetwork.com/wp-content/uploads/2022/01/a-hospital-building.png
January 21

Antitrust Regulators Struggle to Keep Up With Hospital M&A

READ MORE
https://www.mmitnetwork.com/wp-content/uploads/2022/01/WordPress-Featured_AdobeStock_148428808.jpg
January 21

Insurers May Not Be Ready to Implement No Surprises Act

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today